Donald Trump’s controversial picks for his upcoming Cabinet have rattled right past the American public and on to damaging Wall Street. In the wake of Trump’s decision to tap vaccine foe Robert F. Kennedy Jr. to run the Department of Health and Human Services, stocks linked to some of the biggest pharmaceutical companies—including Moderna, Pfizer, and Novavax—plummeted to some of their lowest points of the year. Novavax and BioNTech dropped by more than 7 percent, with “almost all of the losses

Tag-uri: Pfizer Donald Trump